Loading...
Prasugrel in critically ill patients
While prasugrel is indicated for the treatment of myocardial infarction, its effects in the most severely affected patients requiring intensive care is unknown, so that we measured the antiplatelet effects and sparse pharmacokinetics of prasugrel in critically ill patients. Twenty-three patients adm...
Na minha lista:
| Udgivet i: | Thromb Haemost |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Schattauer GmbH
2017
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6292180/ https://ncbi.nlm.nih.gov/pubmed/28692105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1160/TH17-03-0154 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|